Cardiogenic shock (CS) complicating acute myocardial infarction (MI) is a medical emergency with a high mortality rate. Early revascularization of the infarct-related artery is critical, though often insufficient to reverse the hemodynamic embarrassment. Pharmacologic support with vasopressors and inotropes...
Cardiogenic shock (CS) is characterized by low cardiac output and sustained tissue hypoperfusion that may result in end-organ dysfunction and death. CS is associated with high short-term mortality, and its management remains challenging despite recent ad
For non-trauma-related cardiogenic shock, “advanced pediatric life support” is associated with reduced mortality [OR 0.58 (0.4–0.84)] and functional morbidity [OR 0.13 (0.04–0.41)] [19]. No benefit has been observed when high doses of adrenaline (0.1 mg/kg IV) are injected compared wit...
Contemporary management of cardiogenic shock: age is opportunity. This led to the American College of Cardiology/American Heart Association Class 1 Guideline recommending ERV limited to those < 75 years old, without a ... JS Hochman,AH Skolnick - 《Jacc Cardiovascular Interventions》 被引量: 33...
Cardiogenic shock (CS) remains a deadly disease entity challenging patients, caregivers, and communities across the globe. CS can rapidly lead to the development of hypoperfusion and end-organ dysfunction, transforming a predictable hemodynamic event into a potential high-resource, intense, hemometabolic...
Cardiogenic shock is a highly common clinical entity and is characterized by high mortality. Its prompt recognition, identification of the underlying etiology, and assessment of the severity of hemodynamic dysfunction are crucial for accurate management of this condition. Echocardiography is the most usefu...
Outcomes with Invasive vs Conservative Management of Cardiogenic Shock Complicating Acute Myocardial Infarctiondoi:10.1016/j.amjmed.2014.12.009CardiogenicConservativeInvasiveShockBackground In the SHOCK trial, an invasive strategy of early revascularization was associated with a significant mortality benefit at ...
Management of Cardiogenic Shock Before and After Exclusion From Reporting JN Learning™ is the home for CME and MOC from the JAMA Network. Search by specialty or US state and earn AMA PRA Category 1 Credit(s)™ from articles, audio, Clinical Challenges and more. Learn more about CME/MO...
Unlike for septic shock, there are no specific international recommendations regarding the management of cardiogenic shock (CS) in critically ill patients. We present herein recommendations for the management of cardiogenic shock in adults, developed with the Grading of Recommendations Assessment, Developmen...
Chronic vasodilator therapy in the management of cardiogenic shock and intractable left ventricular failure. Ann Intern Med.1974;81:777-780.Google Scholar 61. Elkayam U, Johnson JV, Shotan A. et al. Double-blind, placebo-controlled study to evaluate the effect of organic nitrates in patients ...